168 related articles for article (PubMed ID: 28964586)
1. Hospital Quality Factors Influencing the Mobility of Patients for Radical Prostate Cancer Radiation Therapy: A National Population-Based Study.
Aggarwal A; Lewis D; Sujenthiran A; Charman SC; Sullivan R; Payne H; Mason M; van der Meulen J
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1261-1270. PubMed ID: 28964586
[TBL] [Abstract][Full Text] [Related]
2. Determinants of Patient Mobility for Prostate Cancer Surgery: A Population-based Study of Choice and Competition.
Aggarwal A; Lewis D; Charman SC; Mason M; Clarke N; Sullivan R; van der Meulen J
Eur Urol; 2018 Jun; 73(6):822-825. PubMed ID: 28760646
[TBL] [Abstract][Full Text] [Related]
3. Association Between Travel Distance and Choice of Treatment for Prostate Cancer: Does Geography Reduce Patient Choice?
Muralidhar V; Rose BS; Chen YW; Nezolosky MD; Nguyen PL
Int J Radiat Oncol Biol Phys; 2016 Oct; 96(2):313-317. PubMed ID: 27496390
[TBL] [Abstract][Full Text] [Related]
4. Simulating the impact of centralization of prostate cancer surgery services on travel burden and equity in the English National Health Service: A national population based model for health service re-design.
Aggarwal A; van der Geest SA; Lewis D; van der Meulen J; Varkevisser M
Cancer Med; 2020 Jun; 9(12):4175-4184. PubMed ID: 32329227
[TBL] [Abstract][Full Text] [Related]
5. Effect of patient choice and hospital competition on service configuration and technology adoption within cancer surgery: a national, population-based study.
Aggarwal A; Lewis D; Mason M; Purushotham A; Sullivan R; van der Meulen J
Lancet Oncol; 2017 Nov; 18(11):1445-1453. PubMed ID: 28986012
[TBL] [Abstract][Full Text] [Related]
6. Impact of centralization of prostate cancer services on the choice of radical treatment.
Aggarwal A; Han L; Tree A; Lewis D; Roques T; Sangar V; van der Meulen J
BJU Int; 2023 Jan; 131(1):53-62. PubMed ID: 35726400
[TBL] [Abstract][Full Text] [Related]
7. Association of Quality and Technology With Patient Mobility for Colorectal Cancer Surgery.
Aggarwal A; Han L; Boyle J; Lewis D; Kuyruba A; Braun M; Walker K; Fearnhead N; Sullivan R; van der Meulen J
JAMA Surg; 2023 Jan; 158(1):e225461. PubMed ID: 36350616
[TBL] [Abstract][Full Text] [Related]
8. Association of travel time, patient characteristics, and hospital quality with patient mobility for breast cancer surgery: A national population-based study.
Aggarwal A; Han L; Lewis D; Costigan J; Hubbard A; Taylor J; Rigg A; Purushotham A; van der Meulen J
Cancer; 2024 Apr; 130(8):1221-1233. PubMed ID: 38186226
[TBL] [Abstract][Full Text] [Related]
9. The impact of transportation mode, socioeconomic deprivation and rurality on travel times to radiotherapy and surgical services for patients with prostate cancer: A national population-based evaluation.
Han L; Sullivan R; Tree A; Lewis D; Price P; Sangar V; van der Meulen J; Aggarwal A
Radiother Oncol; 2024 Mar; 192():110092. PubMed ID: 38219910
[TBL] [Abstract][Full Text] [Related]
10. Geographical access to radiation therapy in North Queensland: a retrospective analysis of patient travel to radiation therapy before and after the opening of an additional radiotherapy facility.
Sharma DK; Vangaveti VN; Larkins S
Rural Remote Health; 2016; 16(1):3640. PubMed ID: 26960266
[TBL] [Abstract][Full Text] [Related]
11. Impact of travel distance to the treatment facility on overall mortality in US patients with prostate cancer.
Vetterlein MW; Löppenberg B; Karabon P; Dalela D; Jindal T; Sood A; Chun FK; Trinh QD; Menon M; Abdollah F
Cancer; 2017 Sep; 123(17):3241-3252. PubMed ID: 28472547
[TBL] [Abstract][Full Text] [Related]
12. Impact of patient choice and hospital competition on patient outcomes after prostate cancer surgery: A national population-based study.
Aggarwal AK; Sujenthiran A; Lewis D; Walker K; Cathcart P; Clarke N; Sullivan R; van der Meulen JH
Cancer; 2019 Jun; 125(11):1898-1907. PubMed ID: 30707779
[TBL] [Abstract][Full Text] [Related]
13. Travel distance and stereotactic body radiotherapy for localized prostate cancer.
Mahal BA; Chen YW; Sethi RV; Padilla OA; Yang DD; Chavez J; Muralidhar V; Hu JC; Feng FY; Hoffman KE; Martin NE; Spratt DE; Yu JB; Orio PF; Nguyen PL
Cancer; 2018 Mar; 124(6):1141-1149. PubMed ID: 29231964
[TBL] [Abstract][Full Text] [Related]
14. National Population-Based Study Comparing Treatment-Related Toxicity in Men Who Received Intensity Modulated Versus 3-Dimensional Conformal Radical Radiation Therapy for Prostate Cancer.
Sujenthiran A; Nossiter J; Charman SC; Parry M; Dasgupta P; van der Meulen J; Cathcart PJ; Clarke NW; Payne H; Aggarwal A
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1253-1260. PubMed ID: 28974414
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia.
Baade PD; Youlden DR; Gardiner RA; Ferguson M; Aitken JF; Yaxley J; Chambers SK
BJU Int; 2012 Dec; 110(11 Pt B):E712-9. PubMed ID: 23017157
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Treatment-Related Toxicity With Hypofractionated or Conventionally Fractionated Radiation Therapy for Prostate Cancer: A National Population-Based Study.
Sujenthiran A; Parry M; Nossiter J; Berry B; Cathcart PJ; Clarke NW; Payne H; van der Meulen J; Aggarwal A
Clin Oncol (R Coll Radiol); 2020 Aug; 32(8):501-508. PubMed ID: 32143901
[TBL] [Abstract][Full Text] [Related]
17. Local Protocol Variations for Image Guided Radiation Therapy in the Multicenter Dutch Hypofractionation (HYPRO) Trial: Impact of Rectal Balloon and MRI Delineation on Anorectal Dose and Gastrointestinal Toxicity Levels.
Wortel RC; Heemsbergen WD; Smeenk RJ; Witte MG; Krol SDG; Pos FJ; Incrocci L
Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1243-1252. PubMed ID: 28943074
[TBL] [Abstract][Full Text] [Related]
18. Is moderate hypofractionation accepted as a new standard of care in north america for prostate cancer patients treated with external beam radiotherapy? Survey of genitourinary expert radiation oncologists.
McClelland S; Sandler KA; Degnin C; Chen Y; Hung AY; Mitin TE
Int Braz J Urol; 2019; 45(2):273-287. PubMed ID: 30676300
[TBL] [Abstract][Full Text] [Related]
19. Elective Pelvic Nodal Irradiation With a Simultaneous Hypofractionated Integrated Prostate Boost for Localised Prostate Cancer: Ready for Prime Time?
Cheung P; Niazi T; Faria S; Loblaw A
Clin Oncol (R Coll Radiol); 2020 Mar; 32(3):181-188. PubMed ID: 31926820
[TBL] [Abstract][Full Text] [Related]
20. A pilot study of highly hypofractionated intensity-modulated radiation therapy over 3 weeks for localized prostate cancer.
Nakamura K; Ikeda I; Inokuchi H; Takayama K; Inoue T; Kamba T; Ogawa O; Hiraoka M; Mizowaki T
J Radiat Res; 2018 Sep; 59(5):656-663. PubMed ID: 30085048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
